Wenbin Duan
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006).
Journal: Nature communications
Published: April 30, 2025
Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS).
Journal: International journal of surgery (London, England)
Published: March 25, 2025
ETV4/ALYREF-mediated glycolytic metabolism through PKM2 enhances resistance to ferroptosis and promotes the development of intrahepatic cholangiocarcinoma.
Journal: Cancer & metabolism
Published: October 12, 2024
Development and validation of a multimodal model in predicting severe acute pancreatitis based on radiomics and deep learning.
Journal: International journal of medical informatics
Published: July 02, 2023
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers.
Journal: Journal of hepatocellular carcinoma
Published: September 28, 2022
The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds.
Journal: Journal of gastrointestinal oncology
Published: May 07, 2021
Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
Journal: Cell cycle (Georgetown, Tex.)
Published: March 02, 2021
Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
Journal: Aging
Published: December 09, 2019
Effects of norcantharidin on lipopolysaccharide-induced hepatocyte injury in vitro
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: May 08, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026